Free shipping on all orders over $ 500

 About 1 result found for searched term "HEC96719" (0.122 seconds)

Cat.No.  Name Target
M31160 HEC96719 Farnesoid X Receptor
HEC-96719
HEC96719 is a novel, selective, orally active tricyclic FXR agonist that activates FXR and induces expression of the target genes FGF15 and BSEP for nonalcoholic steatohepatitis (NASH) studies.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.